We demonstrated previously that short term administration of recombinant b-glucuronidase to newborn mice with mu-copolysaccharidosis type VII reduced lysosomal storage in many tissues. Lysosomal storage accumulated gradually af-ter cessation of enzyme replacement therapy. Mice alive at 1 yr of age had decreased bone deformities and less lysosomal storage in cortical neurons. Here we compare the effects of long term enzyme replacement initiated either at birth or at 6 wk of age, and of enzyme administration initiated at birth followed by syngeneic bone marrow transplantation (BMT) at 5 wk of age. Several mice from each treatment group lived to at least 1 yr of age. Liver and spleen samples had b-glucuronidase levels ranging from 2.4 to 19.8 ...
Mice with mucopolysaccharidosis type VII (MPS VII) are devoid of beta-glucuronidase and accumulate g...
Cardiovascular manifestations of lysosomal storage disease (LSD) are a significant health problem fo...
Abstract. The morphological and biochemical consequences of transplanting affected bone marrow from ...
Treatment of mucopolysaccharidosis type VII (MPS VII) mice with recombinant mouse beta-glucuronidase...
Recombinant mouse beta-glucuronidase administered intravenously to newborn mice with mucopolysacchar...
We have previously shown that mucopolysaccharidosis type VII (MPS VII) mice receiving six weekly inj...
Recombinant mouse el-glucuronidase administered intrave-nously to newborn mice with mucopolysacchari...
The toxicity of preparative regimens render neonatal bone marrow transplantation (BMT) for progressi...
The gusmps/gusmps mouse has no beta-glucuronidase activity and develops murine mucopolysaccharidosis...
beta-Glucuronidase injected i.v. into newborn mucopolysaccharidosis VII mice was cleared from the ci...
Murine mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by a recessive...
Treatment of nonmalignant childhood disorders by bone marrow transplantation (BMT) is limited by tox...
Mucopolysaccharidosis type I (MPS I) is an autosomal recessive inherited disease caused by deficienc...
Neonatal bone marrow transplantation (BMT) could offer a novel therapeutic opportunity for genetic d...
Mucopolysaccharidosis type IIIA (MPS IIIA; Sanfilippo syndrome) is a lysosomal storage disorder char...
Mice with mucopolysaccharidosis type VII (MPS VII) are devoid of beta-glucuronidase and accumulate g...
Cardiovascular manifestations of lysosomal storage disease (LSD) are a significant health problem fo...
Abstract. The morphological and biochemical consequences of transplanting affected bone marrow from ...
Treatment of mucopolysaccharidosis type VII (MPS VII) mice with recombinant mouse beta-glucuronidase...
Recombinant mouse beta-glucuronidase administered intravenously to newborn mice with mucopolysacchar...
We have previously shown that mucopolysaccharidosis type VII (MPS VII) mice receiving six weekly inj...
Recombinant mouse el-glucuronidase administered intrave-nously to newborn mice with mucopolysacchari...
The toxicity of preparative regimens render neonatal bone marrow transplantation (BMT) for progressi...
The gusmps/gusmps mouse has no beta-glucuronidase activity and develops murine mucopolysaccharidosis...
beta-Glucuronidase injected i.v. into newborn mucopolysaccharidosis VII mice was cleared from the ci...
Murine mucopolysaccharidosis type VII (MPS VII) is a lysosomal storage disease caused by a recessive...
Treatment of nonmalignant childhood disorders by bone marrow transplantation (BMT) is limited by tox...
Mucopolysaccharidosis type I (MPS I) is an autosomal recessive inherited disease caused by deficienc...
Neonatal bone marrow transplantation (BMT) could offer a novel therapeutic opportunity for genetic d...
Mucopolysaccharidosis type IIIA (MPS IIIA; Sanfilippo syndrome) is a lysosomal storage disorder char...
Mice with mucopolysaccharidosis type VII (MPS VII) are devoid of beta-glucuronidase and accumulate g...
Cardiovascular manifestations of lysosomal storage disease (LSD) are a significant health problem fo...
Abstract. The morphological and biochemical consequences of transplanting affected bone marrow from ...